These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31023605)

  • 1. Changes in Serum Valproate and Levetiracetam Levels Related to Sex Steroids in Adolescent Girls.
    Şahin S; Yılmaz SA; Cansu A; Kamaşak T; Arslan EA; Kaklıkkaya N
    Pediatr Neurol; 2019 Jul; 96():76-78. PubMed ID: 31023605
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome.
    Johannessen Landmark C; Heger K; Lund C; Burns ML; Bjørnvold M; Sætre E; Johannessen SI
    Ther Drug Monit; 2020 Oct; 42(5):744-753. PubMed ID: 32558674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum valproate levels with oral contraceptive use.
    Herzog AG; Farina EL; Blum AS
    Epilepsia; 2005 Jun; 46(6):970-1. PubMed ID: 15946343
    [No Abstract]   [Full Text] [Related]  

  • 4. Catamenial epilepsy: gynecological and hormonal implications. Five case reports.
    Rodriguez Macias KA
    Gynecol Endocrinol; 1996 Apr; 10(2):139-42. PubMed ID: 8701789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizure worsening caused by decreased serum valproate during meropenem therapy.
    Santucci M; Parmeggiani A; Riva R
    J Child Neurol; 2005 May; 20(5):456-7. PubMed ID: 15968935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of sodium valproate in serum by gas chromatography].
    Jing ZZ; Lin CH; Chen S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):614-6. PubMed ID: 16137066
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium valproate (Epilim) in the treatment of refractory epilepsy.
    Lines DR
    N Z Med J; 1978 Jan; 87(603):9-12. PubMed ID: 347342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy].
    Avakian GN; Oleĭnikova OM; Lagutin IuV; Khromykh EA; Bogomazova MA; Delger AB; Avakian GG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):34-9. PubMed ID: 24429946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of the association between catamenial seizure patterns and ovulation.
    Herzog AG; Fowler KM;
    Neurology; 2008 Feb; 70(6):486-7. PubMed ID: 18250294
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy.
    Heo G; Kim SH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):758-764. PubMed ID: 28626875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catamenial epilepsy: hormonal aspects.
    Verrotti A; Laus M; Coppola G; Parisi P; Mohn A; Chiarelli F
    Gynecol Endocrinol; 2010 Nov; 26(11):783-90. PubMed ID: 20518639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of valproate sodium on pituitary gonadotropin in adolescent girls with epilepsy].
    Cai YH; Wang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Sep; 13(9):725-7. PubMed ID: 21924021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Certain aspects of interaction between sodium valproate and other anticonvulsant drugs in the therapy of epilepsy in children.
    Sobaniec W
    Mater Med Pol; 1992; 24(2):115-9. PubMed ID: 1307765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
    Fudio S; Carcas A; Piñana E; Ortega R
    J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of measuring anticonvulsant blood levels in epilepsy.
    Brett E
    Dev Med Child Neurol; 1977 Apr; 19(2):245-51. PubMed ID: 323092
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical utility of unbound antiepileptic drug blood levels in the management of epilepsy.
    Lenn NJ; Robertson M
    Neurology; 1992 May; 42(5):988-90. PubMed ID: 1579255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of subclinical hypothyroidism in ambulatory children with controlled epilepsy on valproate monotherapy.
    Sahu JK; Gulati S; Kabra M; Arya R; Sharma R; Gupta N; Kaleekal T; Reeta Kh; Gupta YK
    J Child Neurol; 2012 May; 27(5):594-7. PubMed ID: 22114214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.
    Nicolai J; Aldenkamp AP; Huizenga JR; Teune LK; Brouwer OF
    J Clin Psychopharmacol; 2007 Apr; 27(2):221-4. PubMed ID: 17414255
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of body mass index and plasma galanin in children with epilepsy following valproate sodium treatment].
    Wang KL; Shi RF; Tang HX
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):488-9. PubMed ID: 20540863
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a manually generated laboratory comment on requesting and performance of valproate assays.
    Jones BJ; Twomey PJ
    J Clin Pathol; 2008 Nov; 61(11):1231. PubMed ID: 18955583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.